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a b s t r a c t 
The purpose of this study was to examine the physicochemical properties of TA ointments and conduct a
human sensory test to assess the properties of those ointments. Physicochemical assessment was done via
near-infrared (NIR) absorption spectroscopy, measurement of water content, microscopy, and measurement
of viscoelasticity. The human sensory test examined 5 aspects (texture, cohesiveness, spreadability, smell,
and feel). Three TA ointments were used: TA-A, a brand-name preparation, and TA-B and TA-C, two generics.
The sensory test revealed signiﬁcant differences between TA-A and TA-B and TA-C in terms of cohesiveness
and spreadability. Signiﬁcant differences between TA-A and TA-C and between TA-B and TA-C in terms of
feel were noted. Microscopic examination revealed that TA-C had good dispersibility while TA-A and TA-B
produced crystallization. NIR spectroscopy revealed differences in absorption spectra attributed to oil and
water content in TAA, TA-B, and TA-C. Measurement of water content indicated water content of 0.06 ±
0.02% for TA-A, 0.08 ± 0.08% for TA-B, and 36.7 ± 1.19% for TA-C. Assessment of viscoelasticity indicated
that stress decreased for all 3 ointments at 35 ◦C compared to that at 25 ◦C. TA-A and TA-B were found to
have a higher percent decrease in stress than was TA-C. These ﬁndings indicate that differences in the types
and content of additives caused differences in the physicochemical properties of individual ointments. In
addition, differences in physicochemical properties presumably resulted in the close correlation between
cohesiveness and spreadability in the sensory test. 
c © 2013 The Authors. Published by Elsevier B.V. Open access under CC BY-NC-ND license. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 1. Introduction 
Generic drugs contain the same active ingredients as brand-name
drugs and are less expensive than their brand-name counterparts,
but they are considered to have equivalent quality. Since generics
and their brand-name counterparts have different additives such as
preservatives and coloring agents, the quality of generics is often
questioned by physicians and pharmacists [ 1 ]. Studies have ques-
tioned the equivalence of some generics to their brand-name coun-
terparts in terms of clinical efﬁcacy and safety, and there is a lack
of clinical information and data on the clinical efﬁcacy and safety of
generics [ 2 , 3 ]. 
Drugs applied to the skin consist of transdermal preparations, in
which drugs act by traveling throughout the body, and topical prepa-
rations, in which drugs are applied externally to a certain place on
the skin. The latter are most often semisolid preparations in the form
of ointments, creams, and gels, liquids such as lotions, and adhesive     
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Open access under CC BY-NC-ND licpreparations such as cataplasms / gel patches and tapes. Bases dif-
fer vastly among brand-name topical preparations and their generic
counterparts, and the characteristics of these bases may differ. Oint-
ments are drugs largely consisting of additives such as thickening
agents and pH adjusters. Clinical efﬁcacy, adverse reactions, and feel
may differ due to factors such as bases and additives and the site of
use despite drugs having the same principal agent [ 4 ]. If the method
and conditions of manufacture differ, then brand-name drugs may
have different properties despite having the same content of active
ingredients and the same additives. Sustained-release preparations
that have the same components but different manufacturers must be
viewed as clinically different drugs [ 5 ]. One example would be differ-
ences in the additives in brand-name and generic tulobuterol patches;
these differences are reportedly a factor that affects drug release [ 6 ].
Thus, information such as differences in the types and ratios of addi-
tives, method of manufacture, and properties is needed regardless of
whether drugs are brand name or generic. 
Topical steroids are used clinically to treat various dermatoses
such as eczema and dermatitis. Topical steroids are used as the prin-
cipal treatment for inﬂammatory dermatoses and pruritus, such as
atopic dermatitis [ 7 ]. These drugs are often prescribed by derma-
tology departments because of their anticipated anti-inﬂammatory
action. However, local adverse reactions to topical steroids include
skin atrophy, thinning skin, vasoconstriction, and skin infections dueense.
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Table 1 
Additives list for TA ointments. 
Formulation Additives 
TA-A Vaseline (PJ), methyl 
p-hydroxybennzoate, propyl 
p-hydroxybennzoate, puriﬁed lanolin 
TA-B Vaseline (PJ), crotamiton 
TA-C Crotamiton, propylene glycol, disodium 
edetate hydrate, carboxyvinyl polymer, 
acidity regulator 
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1o compromised immunity. Caution regarding these adverse reac- 
ions is required, and prolonged use of these steroids is discouraged. 
oreover, abrupt cessation of topical steroids produces a rebound 
henomenon accompanying withdrawal, possibly causing a skin con- 
ition to temporarily worsen. Ceasing use of topical steroids is difﬁ- 
ult, and there are instances when patients will resume using topical 
teroids because of their worsening skin condition due to the rebound 
henomenon and anxiety. The potency of topical steroids is ranked in 
 groups based on the intensity of vasoconstriction [ 8 ]. Depending on 
he site of application, topical steroids must be appropriately selected 
nd used based on their ranked potency. 
Clinical study of topical steroids began with use of cortisone 
cetate to treat dermatoses by Goldman et al. in [ 9 ]. Numerous 
tudies of their pharmacology and therapeutic efﬁcacy [ 9 –11 ] have 
een conducted. 16 α-Hydroxycorticoids were developed when 16 α- 
ydroxycortisol was synthesized by introducing a hydroxyl group 
t the C-16 position of the steroid nucleus. This compound had 
otent glucocorticoid activity and anti-inﬂammatory activity but 
id not cause Na retention. Later, triamcinolone, an analog of 9 α- 
uoroprednisolone with a 16 α –OH, was successfully synthesized. 
riamcinolone acetonide (TA) was developed by suspending triamci- 
olone in acetone to yield a drug with greater bioactivity than 9 α- 
uoroprednisolone. TA preparations are commercially available as 
intments, creams, and injectables, and their usage differs depending 
n the patient’s condition. 
Researchers at the Laboratory of Drug Safety Management pre- 
iously reported a correlation between the physicochemical proper- 
ies and feel of antimicrobial and antiviral creams [ 12 ]. TA ointments 
re drugs with a “medium” ranking as a steroid. Brand-name and 
eneric preparations are commercially available, but the additives in 
reparations differ, so differences in the physicochemical properties 
f individual TA ointments are expected. These differences in physico- 
hemical properties are presumed to affect the feel of these ointments 
o humans, but these physicochemical properties and feel have not 
een studied. 
Results of the current study should provide information on future 
rug selection and use in clinical practice. Thus, the current study 
hysically assessed brand-name and generic TA ointments and it 
ompared the properties of those ointments in conjunction with a 
ensory test with humans. 
. Materials and methods 
.1. Materials 
Three different 0.1% TA ointments were used in the present study: 
he original product, TA-A (AlfresaPharma Co., Ltd., Japan), and two 
eneric products, TA-B (Yoshindou Co., Ltd., Japan) and TA-C (Kaken 
harmaceutical Co., Ltd., Japan). The three products were randomly 
amed TA-A, TA-B, or TA-C. Additives list of each formulation in Table 
 . All other reagents were of special reagent grade. 2.2. Methods 
2.2.1. Sensory test 
The sensory test was carried out by the single-blind method and 
each sample (A, B, and C) was distributed at random. For assessment, 
four aspects—texture, spreadability, cohesiveness (3: yes, 2: slightly, 
1: very few, and 0: no) were evaluated in four steps. And usability (3: 
good, 2: slightly good, 1: slightly worse, and 0: worse)—was evaluated 
in four steps. Moreover, we prepared a general opinion column on 
the assessment sheet. The test was conducted as follows: ﬁrst, the 
subjects washed their hands, then wiped them with a paper towel 
and let them air-dry for 5 min. Thereafter each subject chose one 
50 mg sample of ointment A, B, or C. The ointment was rubbed onto 
the back of a hand using a ﬁnger and a circular motion (10 times). 
Each aspect indicated on the assessment sheet was evaluated within 
5 min, and the next assessment was done 5 min later. Subsequent 
ointments were similarly applied. Ointments were not applied to the 
same part and a different ﬁnger was used each time. The subjects 
avoided applying hand ointment to the tested area an hour prior to the 
test. The subjects were 34 healthy adult volunteers with an average 
age of 23.5 ± 3.51 years (22–58 years). The male-female ratio of the 
subjects was 16:18. The average age of the male was 26.5 ± 9.4 years 
(22–58 years) with an average age of women at the age of 23.7 ±
0.7 years (22–24 years). Those who had medical histories of allergies 
or side effects to these medicines were excluded as candidates. The 
evaluation obtained was changed into an evaluation with a score of 0–
3. A statistical test was then performed using Turkey’s test. In addition, 
the sensory test in this study was conducted with the approval of Josai 
University’s Life Science Research Ethics Screening Committee after 
the study was fully explained to the test subjects and their written 
consent was obtained. 
2.2.2. Microscopy 
Polarization microscopy was performed using a KEYENCE model 
VHX-1000 microscope. 
2.2.3. Near infrared (NIR) absorption spectrometry 
Each sample was analyzed using a Fourier transform near- 
infrared absorption spectrometer, an NIRFlex N-500 analyzer (Buchi 
Labortechnik AG, Switzerland), 10,000–4000 cm −1 measurement fre- 
quency, at 4 cm −1 intervals. Measurement conditions were an optical 
path of 1 nm at 25 ◦C. 
2.2.4. Water content measurement 
The titrimetric determination of water content was performed 
at room temperature using a CA-06 Karl–Fischer moisture con- 
tent meter (Mitsubishi Chemical Co., Ltd., Japan) equipped with 
a coulometric titration system ( n = 3). The Karl–Fischer reagents, 
AQUAMICRON 
®
AX RS as the catholyte and AQUAMICRON 
®
CXU as 
the anolyte, were purchased from Mitsubishi Chemical Co. 
2.2.5. High-performance liquid chromatography assay 
For the assay, 1.0 g of each ointment was weighed accurately and 
placed in a stoppered centrifuge tube. Then 40 mL of chloroform / 
water (1:1) was added and the solution was shaken and then cen- 
trifuged (4000 rpm for 30 min, at 25 ◦C). The portion of the lower 
layer was ﬁltered with a 0.45 μm ﬁlter, and the ﬁltrate served as 
the sample solution. A calibration curve was prepared using TA 
that had separately been dried for 24 h at 105 ◦C. TA was assayed 
using high-performance liquid chromatography (HPLC: e2695, Wa- 
ters). TA assay conditions were a column of Inertsil ODS-3 (4.6 mm 
× 250 mm, Ø5 μm), column temperature of 35 ◦C, mobile phase of 
water / acetonitrile = 2 / 1, and detection wavelength of 240 nm; con- 
ditions were tailored for TA to produce a peak at 9 min. 
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Fig. 1. Sensory test of TA ointments and PJ. *** p < 0.001, * p < 0.01, Tukey test ( n = 34 
Mean ± SD). 
Fig. 2. Light microscopy of TA ointments. (a) TA-A, (b) TA-B, and (c) TA-C. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 3. Near infrared absorption spectrometry of TA. TA crystal, TA ointments, and 
Vaseline (PJ). 
Table 2 
Measurement of water content . 
Water content ( %) 
TA-A TA-B TA-C 
0.06 ± 0.02 0.08 ± 0.08 36.7 ± 1.19 
Values are Mean ± SD ( n = 3). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 2.2.6. Viscosity and viscoelasticity measurements 
Viscosity at 1-s intervals (Epa (Pa s)), stress (Tau (Pa)), and the
loss tangent (tan δ) were measured using a Rheometer (HAAKE MARS
Thermo SCIENTIFIC Co., Ltd.) with a 1 ◦ × R35 cone rotor at 35 ◦C and
25 ◦C. The conditions for measurement of viscosity were a sample
amount of 0.2 mL and a gap of 0.051 mm. The shear rate was gradually
raised from a low shear rate (0 s −1 ) for 1 min and then lowered again
to a low shear rate (0 s −1 ) for 1 min to analyze the return of viscosity.
In addition, viscosity was measured in the range of 1–100 Pa for TA-A
and TA-B and in the range of 1–1000 Pa for TA-C. The conditions for
measurement of viscoelasticity were a sample amount of 2 mL and a
gap of 1 mm. Stress was raised gradually from 1 Pa to 10 Pa. 
tan δ = G ′′ / G ′ 
tan δ is the loss tangent, G ′′ is the loss elastic modulus (Pa) and G ′
is the storage elastic modulus (Pa). 
A human sensory test was conducted with TA ointments desig-
nated TA-A, TA-B, and TA-C and Vaseline (petroleum jelly, denoted
here as PJ) ( Fig. 1 ). Signiﬁcant differences between TA-A, TA-B, and
TA-C in terms of texture were not noted. Signiﬁcant differences be-
tween TA-A vs. TA-B ( p < 0.01), TA-A vs. TA-C ( p < 0.001), and TA-B
vs. TA-C ( p < 0.01) in terms of spreadability were noted. Signiﬁcant
differences between TA-B vs. PJ ( p < 0.01) and TA-C vs. PJ ( p < 0.001)
were also noted. Signiﬁcant differences between TA-A vs. TA-B ( p <
0.01), TA-A vs. TA-C ( p < 0.001), and TA-B vs. TA-C ( p < 0.001) in
terms of cohesiveness were noted. Signiﬁcant differences between
TA-C vs. PJ ( p < 0.001) were noted. Signiﬁcant differences between
TA-A vs. TA-C ( p < 0.001) and TA-B vs. TA-C ( p < 0.001) in terms of
usability were noted. 
Polarization microscopy was next performed to determine the
emulsiﬁcation of TA-A, TA-B, and TA-C ( Fig. 2 ). Results revealed that
TA-C had good dispersibility. In contrast, TA-A and TA-B produced
crystallization, and both were found to have poor dispersibility. NIR absorption spectroscopy was performed on TA-A, TA-B, TA-C,
TA crystal, and Vaseline (petroleum jelly) ( Fig. 3 ). TA-A, TA-B, and
TA-C lacked the absorption spectra characteristic of TA powder. TA-
A and TA-B produced absorption spectra similar to those of PJ, an
additive. In contrast, TA-C produced a spectrum unlike those of TA-
A, TA-B, or PJ. The second derivative of the NIR absorption spectra
( Fig. 4 ) revealed spectra due to oleﬁn groups (–CH 2 ) from oil bases
[ 13 ] at around 4200–4400 cm −1 ( Fig. 4 a). However, TA-C produced a
spectrum located at around 4200–4400 cm −1 , unlike TA-A and TA-B.
Different spectra were produced by TA-A, TA-B, and TA-C at around
4500–4800 cm −1 ( Fig. 4 b). Spectra presumably due to hydroxyl group
(–OH) content [ 14 ] were produced at around 5100–5300 cm −1 ( Fig.
4 c). 
NIR spectroscopy revealed spectra due to hydroxyl groups (–OH)
produced at around 5100–5300 cm −1 by TA-A, TA-B, and TA-C, so
water content was measured using a Karl–Fischer moisture content
meter with a coulometric titration system. Measured water content
was 0.06 ± 0.02% for TA-A, 0.08 ± 0.08% for TA-B, and 36.7 ± 1.19%
for TA-C. TA-C was found to have a higher water content than TA-A
and TA-B ( Table 2 ). 
TA-C produced crystals, so its TA content may differ. Thus, TA
content in the ointments was measured using HPLC. The TA content
in TA-A was 96.6%, that in TA-B was 95.2%, and that in TA-C was 99.9%.
All of the ointments were found to have TA content of 95% or higher. 
Viscoelasticity was measured to examine the effects of differences
in the additives in preparations on viscosity. Measured ﬂow curves
for individual ointments at 25 ◦C and at 35 ◦C are shown in Fig. 5 .
Subjection to stress was found to produce a hysteresis loop for TA-A
and TA-B but produced no such loop for TA-C ( Fig. 5 a). Temperature
was measured as the temperature was changed from 25 ◦C to 35 ◦C,
revealing a decrease in the area of the hysteresis loop. Stress was
found to decrease with a temperature of 35 ◦C compared to one of
25 ◦C ( Fig. 5 b). In addition, TA-A and TA-B were found to have a greater
percent decrease in stress than was TA-C. 
Measurements of viscoelasticity are shown in Fig. 6 . These mea-
surements revealed that TA-A and TA-B had a greater tan δ than did
TA-C. 
4. Discussion 
NIR absorption spectroscopy, measurement of water content, mi-
croscopy, and analysis of aspects such as rheology revealed differ-
ences in the physicochemical properties of the ointments. Results
of the human sensory test suggested that the feel of the ointments
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Fig. 4. 2nd-Derivative near-infrared absorption spectra of triamcinolone acetonide (TA) ointments and Vaseline (PJ). (a) 2nd-derivative near-infrared absorption spectra of TA 
ointments and PJ observed at 4200–4400 cm −1 , (b) 2nd-derivative near-infrared absorption spectra of TA ointments and PJ observed at 4500–4800 cm −1 , and (c) 2nd-derivative 
near-infrared absorption spectra of TA ointments and PJ observed at 5100–5300 cm −1 . 
Fig. 5. Shear stress vs. shear speed curves for TA. (a) 25 ◦C, and (b) 35 ◦C. 
Fig. 6. Tan δ vs. Tau for TA ointments. 
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tiffered. Results suggested a correlation between physicochemical 
roperties and results on the human sensory test. Based on these 
ndings, measuring physicochemical properties using various pieces 
f equipment may provide information correlated with feel in hu- 
ans. 
The sensory test did not indicate that TA-A and TA-B had “a good 
eel.” In contrast, the test indicated that TA-C had “a good feel.” This 
nding may indicate the effects of the presence or absence of crystal- 
ization, water content, and spreading. The particles in food produce 
ritty and unpleasant sensation with feel in humans by Lina et al have 
een reported [ 15 ]. Crystal is affected the usability as well ointments. 
Microscopy indicated potential differences in the dispersibility of 
he ointments. NIR absorption spectroscopy did not reveal an absorption spec- 
trum speciﬁc to TA powder. Presumably, it was not detected since the 
TA content in preparations was 0.1%. Spectra due to oleﬁn groups (–
CH 2 ) produced at around 4200–4400 cm 
−1 by TA-A and TA-B were not 
produced by TA-C [ 13 ]. Different spectra at around 4500–4800 cm −1 
were produced by TA-A, TA-B, and TA-C. Differences between oint- 
ments in terms of the spectra at 5100–5300 cm −1 , presumably due 
to hydroxyl groups (–OH), were noted [ 14 ]. These ﬁndings indicate 
that differences in spectra are presumably due to the differences in 
the types and content of additives in ointments. Differences in the 
absorption of –OH groups that NIR absorption spectroscopy revealed 
and measurements of water content indicated a higher water content 
for TA-C, followed almost equally by TA-A and TA-B. Based on the 
above results, there were differences in oil and water content and dif- 
ferences in ingredients in each of the creams. Accordingly, differences 
in the physical properties of viscosity, viscoelasticity, and spreadabil- 
ity may reﬂect differences in emulsiﬁcation. The different physical 
properties of these creams are likely to result in a different feel when 
the creams are actually applied. Differences in the types and content 
of additives in preparations affect water and oil content. The presence 
of crystals and differences in dispersibility may have affected feel in 
the sensory test. 
Assessments of both the viscosity and elasticity of semisolid prepa- 
rations such as ointments and creams are reﬂected in assessments of 
their internal structures [ 16 ]. Determining rheology is a relatively 
simple and effective technique to compare the structural character- 
istics of creams and an efﬁcient way to obtain information regarding 
their resistance to force. Assessments of structural characteristics are 
known to be an indicator of structural stability [ 17 ]. TA-A and TA-B 
had a greater area under the ﬂow curve and underwent greater stress, 
suggesting that they had a stronger internal structure that was less 
susceptible to disruption compared to TA-C. Differences in suscepti- 
bility to temperature changes may be due to a different oil content 
and water content, i.e. the properties of bases. Oil has a lower speciﬁc 
heat than water, so it is readily affected by temperature. Typically, 
human skin temperature is considered to be about 32 ◦C [ 18 ]. When 
topical preparations are actually used, they are rubbed into the skin, 
resulting in a temperature higher than 32 ◦C due to the heat of fric- 
tion. In the current study, measurement was done at 35 ◦C, reﬂecting 
use of a topical preparation. Physical behavior of preparations inside 
their containers and on the skin may differ. 
TA-A and TA-B had a greater tan δ than TA-C, so they had a pro- 
portionately larger viscosity component. This may have led to greater 
cohesion. 
Typically, adding a solubilizing agent is known to ensure stability 
even at high temperatures and result in a highly viscous preparation. 
TA-B contained crotamiton, a solubilizing agent, and TA-B had slightly 
Y. Inoue et al. / Results in Pharma Sciences 3 (2013) 15–19 19 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 greater viscosity than TA-A. Tajiri et al. studied the correspondence
between ﬂow curves and assessments of spreadability, and they re-
ported that addition of a stabilizer hampered spreadability [ 19 ]. A
preservative that TA-A contained but that TA-B did not presumably
resulted in TA-B having better spreadability in the sensory test than
TA-A. The feel of TA-C was due to differences in water content, pre-
sumably resulting in the better spreadability of TA-C. In general, the
formulation of good spreadability and without being sticky is good
usability. Watery formulation is easy to extent and without the sticky.
Accordingly, TA-C, watery formulation, was used feeling good. 
Tan δ is known to be associated with the pastiness and stickiness of
foods. Thus, tan δ is, when talking about ointments, closely correlated
with cohesiveness on a sensory test [ 20 ]. TA-A and TA-B had a greater
tan δ and a greater cohesiveness, suggesting a correlation with the
sensory test in the current study as well. 
Based on the above results, differences in types and ratios of ad-
ditives in TA ointments and differences in oil and water content due
to those types and ratios of additives were reﬂected in differences
in physical properties, i.e. dispersibility and viscoelasticity. Differ-
ences in physical properties are surmised to cause differences in feel
when ointments are actually applied. In such instances, NIR absorp-
tion spectroscopy, a non-destructive method of analysis, is a useful
way to identify differences in preparations [ 21 ]. Physical assessment
based on NIR absorption spectra leads to information on how prepa-
rations feel to patients and should provide indications of individual
preferences. Thus, physical assessment of preparations can be used as
a way to gather information on drugs, and such assessment can pro-
vide useful information when selecting brand-name or generic drugs.
A study reported that differences in the types and ratios of additives
affect skin penetration [ 18 ]. Differences in physical properties are sur-
mised to potentially lead to differences in clinical efﬁcacy. Differences
in physical properties may also affect skin penetration. In fact, skin
penetration is attributed to physicochemical properties (lipophilic-
ity and hydrophilicity) [ 22 ]. Brand-name drugs and generic drugs are
considered to have equivalent quality, but their physical properties
may differ. Thus, examining the correlation between physical prop-
erties and skin penetration is a topic for the future. 
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